The 2012 SEMDSA Guideline for the Management of type 2 Diabetes

doi:10.1080/22201009.2012.10872277

Cited by 14 publications

(7 citation statements)

References 217 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The mean systolic blood pressure of the study participants was 139.68 (± 21.82) mmHg and mean diastolic blood pressure was 79.91 (± 11.13) mmHg, which concurs with the latest targets of less than 140/80 mmHg in type 2 diabetes mellitus patients set out by the SEMDSA guidelines (Amod et al 2012a). These findings concur with the findings of Amod et al (2012b), who also found blood pressure was relatively well controlled, where participants (n = 701) with type 2 diabetes mellitus had mean systolic blood pressures of 132.9 (± 17.5) mmHg and mean diastolic pressure of 80 (± 10.2) mmHg (Amod et al 2012b).…”

Section: Resultssupporting

confidence: 85%

“…The baseline HbA1c levels of participants were categorised into age group and risk category to establish the proportion of participants with results within and outside target ranges as per the Western Cape Province guidelines (Western Cape Government Health 2012), which are based on SEMDSA guidelines (Amod et al 2012a). In addition to baseline measurements, this study followed the glycaemic monitoring results and the follow-up prescriptions for each participant over an 18 month period.…”

Section: Data Collection and Analysismentioning

confidence: 99%

“…Two South African studies have found that only about 30% of patients reach their glycaemic targets (Amod, Riback & Schoeman 2012b;Klisiewicz & Raal 2009). Patient follow-up and therapy adjustments are important when monitoring glycaemic control and SEMDSA (Amod et al 2012a) and the American Diabetes Association (2014) have stated their concern over the considerable variations in the regularity of follow-up visits and therapy adjustments in the management of type 2 diabetes mellitus. The worldwide diabetes 'epidemic' is expected to affect developing countries more than developed ones; hence studies to determine the usefulness of HbA1c as a diagnostic tool in these populations are needed, as there is a paucity of data from these communities compared to Western countries (Zemlin et al 2011).…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Describing medicine therapy management of type 2 diabetes mellitus at primary health care facilities in Cape Town

Monanabela

Huyssteen

Coetzee

2019

Health SA Gesondheid

View full text Add to dashboard Cite

To describe the use of glycated haemoglobin (HbA1c) and fasting plasma glucose results in guiding treatment changes in patients with type 2 diabetes mellitus.Setting: Public sector primary health care facilities in the Cape Town Metropolitan Region in South Africa.Method: Retrospective, descriptive study design was employed. Data for an 18-month period were collected during 2014 and 2015. Data were collected from patient medical records and included baseline demographics, laboratory monitoring tests and the patients' last three prescriptions. Results:The study consisted of 575 participants (64% female) with an average age of 57 (± 11.38) years. The average baseline HbA1c for 493 participants with at least one result was 8.78% (± 1.63), and only 28% of these participants reached the glycaemic target at consequent consultations. HbA1c levels were available to guide 245 prescription changes, of which 181 of these results were outside of the target range. Of these, 15.5% had appropriate therapy adjustments, 78.4% had no change or a lateral change in their follow-up prescriptions, and 6.1% had therapy adjustments opposite to what guidelines suggest. Conclusion:Glycaemic monitoring indicated consistent suboptimal glycaemic control in more than 60% of participants. Medicine prescribing patterns did not align with the prescribed local guidelines, Society for Metabolism, Endocrinology and Diabetes of South Africa (SEMDSA). The appropriate use and interpretation of HbA1c at a clinic level should be emphasised to promote rational use of medicines that minimise acute hospitalisation episodes and optimise patients' long-term health outcomes.

show abstract

Section: Resultssupporting

confidence: 85%

Section: Data Collection and Analysismentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Describing medicine therapy management of type 2 diabetes mellitus at primary health care facilities in Cape Town

Monanabela

Huyssteen

Coetzee

2019

Health SA Gesondheid

View full text Add to dashboard Cite

show abstract

“…It is essential that efforts are made to diagnose diabetes early to prevent the complications and to begin early management interventions of the disease (Ramachandran, 2014). Early control of glycaemia and dyslipidaemia, together with regular examination for macrovascular and microvascular complications, with appropriate and timely interventions, are the only ways to prevent and reduce morbidity and mortality related to diabetes (Amod, Motala, Levitt et al, 2012).…”

Section: Introductionmentioning

confidence: 99%

What are the Experiences and Needs of Primary Care Nurses in Caring for Patients With Type 2 Diabetes in a Rural Village in South Africa? An Exploratory Study

Sechabe¹,

Mothiba²,

Bastiaens³

2019

GJHS

View full text Add to dashboard Cite

Since 1994, the emphasis in the provision of health services in South Africa has shifted from hospital-based care to a community-based comprehensive primary health care system, especially important in the management of chronic diseases. However, primary health care professional nurses are not well trained to manage chronic conditions like type 2 diabetes. Therefore, this study aimed to explore the experiences and needs of primary care nurses as a basis for the development of a training programme for professional nurses who care for T2D patients. A qualitative descriptive approach was employed, using individual interviews with primary health care nurses caring for T2D patients in the Ga-Dikgale village clinics. Ethical considerations were observed throughout the study and quality supportive measures were employed. Three main themes emerged from the study findings which address the current practices and knowledge of professional nurses related to care provided to diabetes patients, the challenges experienced by professional nurses during the provision of care to diabetes patients on treatment and their training experiences, gaps and needs. A need for continuing education for professional nurses related to the care of patients with diabetes was identified. The results of this study will be used to develop a training programme to improve the knowledge and skills of professional nurses and to improve the quality of care of patients with type 2 diabetes.

show abstract

“…Drivers with diabetes mellitus, similarly, are regarded as higher-risk drivers, owing mainly to the possibility of hypoglycaemic incidents while driving, [7] but also to other potential complications such as stroke, cataracts, or retinopathy. [8] Hypoglycaemia is of particular concern for drivers, as it can result in clumsiness, confusion, seizures, loss of consciousness, and death.…”

Section: Risks Posed By Diabetic Driversmentioning

confidence: 99%

Confidentiality and fitness to drive: Professional, ethical, and legal duties in the case of the diabetic bus driver

Wareham

2017

S Afr Med J

View full text Add to dashboard Cite

The 2012 SEMDSA Guideline for the Management of type 2 Diabetes

Abstract: Raubenheimer P; Guideline Committee. The 2012 SEMDSA guideline for the management of type 2 diabetes. JEMDSA. 2012;17(1):S1-S94.

Cited by 14 publications

References 217 publications

Describing medicine therapy management of type 2 diabetes mellitus at primary health care facilities in Cape Town

Describing medicine therapy management of type 2 diabetes mellitus at primary health care facilities in Cape Town

What are the Experiences and Needs of Primary Care Nurses in Caring for Patients With Type 2 Diabetes in a Rural Village in South Africa? An Exploratory Study

Confidentiality and fitness to drive: Professional, ethical, and legal duties in the case of the diabetic bus driver

Contact Info

Product

Resources

About